SCHEMBL3276344

SCHEMBL3276344

COc1ccc2c(c1O)C(=O)c1ccc(O)cc1C2=O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.74
MEN1 O00255 4/20 0.74
KMT2A Q03164 4/20 0.74
NPC1 O15118 3/20 0.74
RAB9A P51151 3/20 0.74
TTR P02766 1/20 0.64
EPHX2 P34913 1/20 0.58
MAOA P21397 2/20 0.56
ESR1 P03372 1/20 0.56
UGT1A1 P22309 1/20 0.56
MAOB P27338 1/20 0.56
ESR2 Q92731 1/20 0.56
SMN1; SMN2 Q16637 3/20 0.50
ELANE P08246 5/20 0.48
KDM4E B2RXH2 4/20 0.46
ALDH1A1 P00352 4/20 0.46
TDP1 Q9NUW8 2/20 0.46
USP2 O75604 1/20 0.46
DUSP3 P51452 1/20 0.46
MITF O75030 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1426486 0.85 MAPT (1.00) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL31441205 0.85 MAPT (1.00) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL29929605 0.85 MAPT (1.00) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL3271823 0.84 MEN1 (0.53) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL29778104 0.84 MEN1 (0.53) MAPTMEN1KMT2ANPC1RAB9A
Nobilone SCHEMBL30502482 0.79 ESR1 (0.58) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL29614714 0.79 ELANE (0.72) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL10909335 0.79 ELANE (0.72) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL1507679 0.78 TTR (1.00) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL1495097 0.78 TTR (1.00) MAPTMEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114224947-A A Chinese medicinal capsule, GECHONGCHUANYU Capsule, and its preparation method and optimization method 杨志军 2022-03-25 CN disclosed
CN-107397967-B Air purifying agent capable of effectively solving air pollutants in parking place 王婧宁 2020-07-03 CN disclosed
CN-110522808-A A kind of anti-treating caput femoris necrosis Chinese medicine composition and preparation method thereof YIWU LINGCHUAN TECH CO LTD 2019-12-03 CN disclosed
CN-108852628-A Antibacterial twin-core medicinal sanitary towel 广西舒雅护理用品有限公司 2018-11-23 CN disclosed
CN-108295591-A Pollution cleanup composition based on plant extracts 国润生物科技(深圳)有限公司 2018-07-20 CN disclosed
CN-108261861-A Clarifying smoke composition 国润生物科技(深圳)有限公司 2018-07-10 CN disclosed
CN-105396120-B A kind of drug for treating acne hole and depressed scar 上海资医堂生物科技有限公司 2018-05-29 CN disclosed
CN-107397967-A Can effectively solve the air purifying preparation of parking facility air pollutants 王婧宁 2017-11-28 CN disclosed
CN-107297128-A Can the new decorating house of fast purification air freshener 王婧宁 2017-10-27 CN disclosed
CN-105396120-A Drug for treating pox pits and pitting scars SHANGHAI CIEIANG BIOTECHNOLOGY CO LTD 2016-03-16 CN disclosed
CN-104473167-A Health-care food for improving male prostatic diseases WEIHAI BAIHE BIO TECHNOLOGY CO LTD 2015-04-01 CN disclosed
CN-104304539-A Cancer-eliminating tea containing flavonoid compounds and preparation method thereof ZHOU JICHUN 2015-01-28 CN disclosed
CN-104138496-A Pills for treating dysuria of the old SHANGHAI PUDONG GAOXING BIOTECHNOLOGY RES INST 2014-11-12 CN disclosed
US-7691418-B2 Composition for inhibiting or preventing the formation of a biofilm OYSTERSHELL NV (BE) 2010-04-06 US disclosed
CN-101356997-A Preparation method of alcohol extract of morinda root and use thereof in cigarette LONGYAN TOBACCO INDUSTRY CO LT (CN) 2009-02-04 CN disclosed
CN-101356996-A Preparation method of water extract of morinda root and use thereof in cigarette LONGYAN TOBACCO INDUSTRY CO LT (CN) 2009-02-04 CN disclosed
US-20070258913-A1 Composition for Inhibiting or Preventing the Formation of a Biofilm OYSTERSHELL NV (BE) 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070258913-A1 Composition for Inhibiting or Preventing the Formation of a Biofilm NQO2, NFKBIA, CROCC MAPT 4695/4885MEN1 3614/4885KMT2A 3594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.